TNF and autoimmune disease: Potential confounding was likely because of indication bias, with TNF inhibitors being administered to patients with moderate to severe disease.46,47 However, we selected the control participants from the same study population as the patients, which required the patients with autoimmune disease to have been treated at some point with a DMT.